New Promising Treatment Combines CRISPR With Stem Cell Therapy to Reverse Diabetes in Mice
One of the most common chronic disease in children and adolescents is type 1 diabetes; studies reveal that more than 40 million individuals are affected worldwide by the condition. In patients with type 1 diabetes, the pancreas no longer produces insulin because the body’s immune system attacks its beta cells for reasons still unknown. Today’s …
Weekly Coronavirus Resources for People with T1D — 5/1/2020
Your Daily News Roundup We’re all in this together! Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place. Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better cope with …
Continue reading “Weekly Coronavirus Resources for People with T1D — 5/1/2020”
CEO DAVID WALTON INTERVIEWED ON THE JUICEBOX PODCAST
David Walton, CEO of T1D Exchange, sat down this week with Scott Benner, host of the Juicebox Podcast, to talk about their respective history with type 1 diabetes. The conversation covered a wide range of topics: Scott and Dave discussed their personal relationships with T1D, experiences in the industry, and strategies for dealing with the disease. …
Continue reading “CEO DAVID WALTON INTERVIEWED ON THE JUICEBOX PODCAST”
Dexcom Launches Crucial Patient Assistance Program As Result of COVID-19 Pandemic
The COVID-19 pandemic has put immense pressure on both individuals with T1D, and the organizations who provide them with vital supplies and medications. While there’s no doubt that people with T1D face a more uncertain and risk-filled future as we navigate quarantine and social distancing, there have been some promising steps from several sides that have …
Continue reading “Dexcom Launches Crucial Patient Assistance Program As Result of COVID-19 Pandemic”
Boston 25 News – Boston-Based Study Blazing Trail on COVID-19 Connection to Diabetes
The ongoing outbreak of the novel respiratory disease COVID-19 has become a significant threat to global health and individuals with pre-existing medical conditions. To gain a deeper understanding of how the coronavirus is affecting people with type 1 diabetes, T1D Exchange is leading a first-of-its-kind COVID-19 research surveillance study in partnership with more than 50 …
Weekly Coronavirus Resources for People with T1D
We’re going to take the opportunity to share out some critical resources each week that may help people get through this challenging coronavirus pandemic with the help of partners and experts.
T1D Exchange Announces Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes
T1D Exchange today announced the launch of a population health surveillance study of individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). The results of the study will be used to better understand the etiology and potential outcomes in COVID-19 patients and inform future clinical quality improvement activities to better respond to the global pandemic.
Eli Lilly Announces Groundbreaking Affordable Insulin Program.
Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak. Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with …
Continue reading “Eli Lilly Announces Groundbreaking Affordable Insulin Program.”
The T1D Exchange Guide to Dealing with Diabetes and Coronavirus (COVID-19)
The last few weeks have been a harrowing experience for thousands of people around the world. The public health crisis caused by the novel coronavirus COVID-19 threatens to overwhelm doctors and hospitals with an alarming number of deaths and infections.
2020 Data: Current Insights from the T1D Exchange Registry
The T1D Exchange Registry launched last year, and it’s begun to provide a fascinating and vital look into some of the more detailed aspects of life with type 1 diabetes. From your age of diagnosis to frequency of testing, we’ve learned more about how you’re living, working, and caring for diabetes across the country.
